跳至主要内容
临床试验/EUCTR2008-008010-39-DE
EUCTR2008-008010-39-DE进行中(未招募)不适用

The Sensivity and Specificity of the Modified Helicobacter Test INFAI Using New Test Meal with 13C-Urea Breath Test in Helicobacter Pylori Positive and Negative Patients with Dyspepsia Taking Proton Pump Inhibitors - PPI Study

INFAI Institut für biomedizinische Analytik und NMR Imaging GmbH0 个研究点目标入组 86 人开始时间: 2009年2月24日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ·Male and female patients of at least 18 years of age
  • ·All acid-related disorders requiring long-term PPI treatment including functional
  • dyspepsia according Rome II classification.
  • ·Positive or negative standard 13C-UBT at screening.
  • ·Diagnosis of Hp infection confirmed or excluded by combination of culture#,
  • histology* and rapid** urease test (PyloriTek®, Serim Research Corp., Elkhart,
  • USA) on samples obtained by endoscopy:
  • -True positive: culture and/or (histology and rapid urease test) are positive
  • -True negative: at least two tests are negative and culture is not positive
  • -True negative: culture not evaluable and both histology and urease test are
  • Culture will be based on antrum biopsies.
  • 4 endoscopic biopsies from the antrum and 1 biopsy from the corpus, and 1
  • biopsy from the angular fold will be sampled. Histological processing and
  • evaluation will be performed for at least one sample of the antrum and the
  • Rapid urease test will be performed on the sample of angular fold biopsy.
  • ·Written informed consent of the patient.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ·Previous Hp eradication therapy.
  • ·Intake of PPI, H2 receptor antagonists, NSAIDs, antibiotics, antisecretory drugs,
  • bismuth compounds, or sucralfate in the 4 weeks prior to enrolment.
  • ·Manifest coagulopathy or any other disorder according to which endoscopy and/or
  • biopsies are contraindicated.
  • ·Participation in a clinical trial with another not approved drug within 30 days before
  • entering the study and/or previous participation in this study.

研究者

发起方
INFAI Institut für biomedizinische Analytik und NMR Imaging GmbH

相似试验

The Sensivity and Specificity of the Modified... | 临床试验